Claforan and Toxic skin eruption - a phase IV clinical study of FDA data

Summary:

Toxic skin eruption is reported as a side effect among people who take Claforan (cefotaxime sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Hiv infection.

The phase IV clinical study analyzes which people have Toxic skin eruption when taking Claforan. It is created by eHealthMe based on reports of 2,524 people who have side effects when taking Claforan from the FDA, and is updated regularly.

What is Claforan?

Claforan has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,527 Claforan users. Check the latest studies of Claforan.

What is Toxic skin eruption?

Toxic skin eruption (skin breakdown due to toxic substance) is found to be associated with 637 drugs and 1,064 conditions by eHealthMe. Check the latest studies of Toxic skin eruption.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

2,524 people reported to have side effects when taking Claforan.
Among them, 41 people (1.62%) have Toxic skin eruption.

Could Claforan cause Toxic skin eruption?

Among these 41 people:

How long have people been on Claforan when they have Toxic skin eruption? *

What is the gender of people who have Toxic skin eruption when taking Claforan? *

female: 35.9 %
male: 64.1 %

What is the age of people who have Toxic skin eruption when taking Claforan? *

What are other drugs people take besides Claforan? *

What are other side effects people have besides Toxic skin eruption? *

Fever: 14 people, 34.15%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 11 people, 26.83%
Itching: 6 people, 14.63%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 6 people, 14.63%
Rashes (redness): 5 people, 12.20%
Acute Kidney Failure: 3 people, 7.32%
Klebsiella Test Positive: 2 people, 4.88%
Rash Pustular (redness with pustules): 2 people, 4.88%
Inflammation: 2 people, 4.88%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 4.88%

What are the existing conditions these people have? *

Hiv Infection: 7 people, 17.07%
High Blood Pressure: 5 people, 12.20%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 12.20%
Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 12.20%
Device Related Infection: 5 people, 12.20%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 7.32%
Lung Disorder (lung disease): 3 people, 7.32%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 7.32%
Multiple Myeloma (cancer of the plasma cells): 2 people, 4.88%
Mediastinitis (inflammation of the tissues in the mid-chest): 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Claforan and have Toxic skin eruption?

- Check whether Toxic skin eruption is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claforan:

Claforan (2,527 reports)

Browse all side effects of Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toxic skin eruption:

Toxic skin eruption (637 drugs)

Browse all the conditions that are associated with Toxic skin eruption:

Toxic skin eruption (1,064 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Claforan) and Claforan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.